{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:01:49Z","timestamp":1782432109683,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajg.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T07:45:52Z","timestamp":1631519152000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-5904","authenticated-orcid":false,"given":"Cem","family":"Ercalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Cetin","family":"Baskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebahat","family":"Ozdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Butun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2021.05.020_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.37829","article-title":"Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?","volume":"65","author":"Baeten","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2021.05.020_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-857X(21)00888-7","article-title":"Ankylosing spondylitis and other spondyloarthropathies","volume":"16","author":"Khan","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ajg.2021.05.020_b0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajg.2021.05.020_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/00365521.2011.648953","article-title":"Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum","volume":"47","author":"Klingberg","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ajg.2021.05.020_b0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2012.08.012","article-title":"Pathophysiology and role of the gastrointestinal system in spondyloarthritides","volume":"38","author":"Jacques","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ajg.2021.05.020_b0030","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.22812","article-title":"A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland","volume":"56","author":"Thjodleifsson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2021.05.020_b0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/j.gastro.2003.08.035","article-title":"Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis","volume":"125","author":"Bjarnason","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2021.05.020_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajg.2021.05.020_b0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s13075-019-2018-4","article-title":"A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajg.2021.05.020_b0050","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.1038\/npjgenmed.2016.8","article-title":"Exome-wide study of ankylosing spondylitis demonstrates additional shared genetic background with inflammatory bowel disease","volume":"1","author":"Robinson","year":"2016","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.ajg.2021.05.020_b0055","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.3748\/wjg.15.2463","article-title":"Non-invasive investigation in patients with inflammatory joint disease","volume":"15","author":"Pont","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajg.2021.05.020_b0060","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar4475","article-title":"Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sj\u00f6gren's syndrome and rheumatoid arthritis","volume":"16","author":"Andr\u00e9asson","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ajg.2021.05.020_b0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ibd.20820","article-title":"Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease","volume":"15","author":"Quail","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajg.2021.05.020_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187153007780059441","article-title":"Does calprotectin represent a regulatory factor in host defense or a drug target in inflammatory disease?","volume":"7","author":"Baldassarre","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.ajg.2021.05.020_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","article-title":"Improved assay for fecal calprotectin","volume":"292","author":"T\u00f8n","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajg.2021.05.020_b0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","article-title":"A simple method for assessing intestinal inflammation in Crohn's disease","volume":"47","author":"Tibble","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.ajg.2021.05.020_b0085","doi-asserted-by":"crossref","unstructured":"Waugh N, Cummins E, Royle P, Kandala NB, Shyangdan D, Arasaradnam R, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 2013; 17: 1-211.","DOI":"10.3310\/hta17550"},{"key":"10.1016\/j.ajg.2021.05.020_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-230X-14-57","article-title":"Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness","volume":"14","author":"Burri","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajg.2021.05.020_b0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2478\/folmed-2018-0071","article-title":"Role of fecal calprotectin as a noninvasive indicator for ulcerative colitis disease activity","volume":"61","author":"Nakov","year":"2019","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.ajg.2021.05.020_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.arcmed.2019.04.003","article-title":"Fecal Calprotectin, Gut Inflammation and Spondyloarthritis","volume":"50","author":"Simioni","year":"2019","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajg.2021.05.020_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-016-0132-2","article-title":"Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use","volume":"15","author":"Aalto","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ajg.2021.05.020_b0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajg.2021.05.020_b0115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ecco-jcc\/jjz205","article-title":"Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review","volume":"5","author":"Fauny","year":"2020","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.ajg.2021.05.020_b0120","first-page":"532","article-title":"Inflammatory bowel disease markers in the stool of patients with ankylosing spondylitis compared to healthy controls","volume":"10","author":"Matzkies","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2021.05.020_b0125","doi-asserted-by":"crossref","unstructured":"Olofsson T, Lindqvist E, Mogard E, Andr\u00e9asson K, Marsal J, Geijer M, et al. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort. Rheumatology (Oxford); 2019: 58(7):1176-1187.","DOI":"10.1093\/rheumatology\/key427"},{"key":"10.1016\/j.ajg.2021.05.020_b0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365521.2015.1081399","article-title":"Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease","volume":"51","author":"Mirsepasi-Lauridsen","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ajg.2021.05.020_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2050640613518201","article-title":"Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease","volume":"2","author":"Labaere","year":"2014","journal-title":"Unit Eur Gastroenterol J"},{"key":"10.1016\/j.ajg.2021.05.020_b0140","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(84)92739-9","article-title":"Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs","volume":"324","author":"Bjarnason","year":"1984","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ajg.2021.05.020_b0145","first-page":"71","article-title":"Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis","volume":"16","author":"Duran","year":"2016","journal-title":"Bosnian J Basic Med Sci"},{"key":"10.1016\/j.ajg.2021.05.020_b0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.23275","article-title":"Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs","volume":"4","author":"Song","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2021.05.020_b0155","first-page":"451","article-title":"Ankylosing spondylitis and bowel disease Best Practice & Research","volume":"3","author":"Rudwaleit","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajg.2021.05.020_b0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajg.2021.05.020_b0165","doi-asserted-by":"crossref","unstructured":"Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. The Cochrane database of systematic reviews 2004: Cd003574.","DOI":"10.1002\/14651858.CD003574.pub2"},{"key":"10.1016\/j.ajg.2021.05.020_b0170","doi-asserted-by":"crossref","unstructured":"Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory Crohn\u2019s disease. The Cochrane database of systematic reviews 2005: Cd003459.","DOI":"10.1002\/14651858.CD003459.pub2"},{"key":"10.1016\/j.ajg.2021.05.020_b0175","doi-asserted-by":"crossref","unstructured":"Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. The Cochrane database of systematic reviews 2006: Cd005112.","DOI":"10.1002\/14651858.CD005112.pub2"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:44:23Z","timestamp":1761659063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197921000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1687197921000423"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2021.05.020","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}